| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
 |
|
Site Navigation
| ALS News & Research For postings of news or research links and articles related to ALS |
advertisement
| Reply |
|
|
Thread Tools | Display Modes |
|
|
| ALS News & Research For postings of news or research links and articles related to ALS |
| Reply |
|
|
Thread Tools | Display Modes |
02-15-2017, 08:54 AM
|
#1 | |||
|
||||
|
Grand Magnate
|
Neuraltus NP001 Phase 2 Trial: Targeting Neuroinflammation to Slow ALS Progression
ALS Trials | ALS Clinical Research | Neuraltus NP 1 Phase 2 Trial: Targeting Neuroinflammation to Slow ALS Progression | Educational Webinars | For People with ALS & Caregivers | Northeast Amyotrophic Lateral Sclerosis (ALS) Consortium |
|||
|
 Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Neuraltus Enrolls Nearly Half of Patients in Phase 2 Confirmation Trial of NP001 for | ALS News & Research | |||
| Neuraltus Pharmaceuticals Provides Enrollment Update on Confirmatory Phase 2 Study of | ALS News & Research | |||
| Neuraltus Pharmaceuticals Initiates Confirmatory Phase 2 Study of NP001 in Patients w | ALS News & Research | |||
| Neuraltus Pharmaceuticals Announces Plans 2nd Phase 2 Study of NP001 in ALS . . . | ALS News & Research | |||
| First human dosed in Phase 1 trial of antibody targeting alpha synuclein | Parkinson's Disease | |||
Neuraltus NP001 Phase 2 Trial: Targeting
Linear Mode
